| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $127.7M | $158.2M | $155.2M |
| YoY Revenue Growth % | -19.3% | +2.0% | — |
| Gross Profit | $28.5M | $45.2M | — |
| Gross Margin % | 22.3% | 28.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$213.9M | -$133.4M | -$39.0M |
| Operating Margin % | -167.5% | -84.3% | -25.2% |
| Net Income (GAAP) | -$294.0M | -$296.0M | -$71.0M |
| EBITDA (Normalized) | -$213.5M | -$133.0M | -$33.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$42.0M | -$38.1M | -$18.3M |
| Capital Expenditures (CapEx) | $525.0K | $484.0K | $7.0M |
| Free Cash Flow (FCF) | -$42.5M | -$38.6M | -$25.3M |
| FCF Margin % | -33.3% | -24.4% | -16.3% |
| Return on Invested Capital (ROIC %) | -27.5% | -45.0% | -7.2% |
| Cash & Short-Term Equivalents | $87.1M | $50.1M | — |
| Total Debt (Short + Long Term) | $90.5M | $135.4M | $165.4M |
| Total Stockholders' Equity | $611.9M | -$3.7M | $339.3M |